Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00730002 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus
A NA study of Neuropsychiatric Systemic Lupus Erythematosus, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT00730002 is a NA study of Neuropsychiatric Systemic Lupus Erythematosus that has completed, run by University of Michigan. The registered enrollment target is 66 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00730002, a NA study of Neuropsychiatric Systemic Lupus Erythematosus, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if three functional Magnetic Resonance brain imaging techniques: Magnetic Resonance Spectroscopy(MRS),Magnetic Resonance perfusion, and Diffusion Tensor Imaging(DTI) can detect brain alterations distinctive for neuropsychiatric systemic lupus erythematosus (NPSLE)and systemic lupus erythematosus(SLE).
Conditions Studied
Interventions
- PROCEDURE Magnetic resonance imaging
- PROCEDURE Magnetic Resonance Angiography (MRA)
- PROCEDURE MRA
- PROCEDURE diffusion Imaging
Study Locations (1)
Michigan
- University of Michigan Health Systems - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2008-03 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00730002
The ClinicalTrials.gov registry entry for NCT00730002 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neuropsychiatric Systemic Lupus Erythematosus appearing as the primary indexed condition, and to 4 interventions - of which Magnetic resonance imaging is the first listed.
NCT00730002 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00730002 about?
NCT00730002 is a clinical study titled "Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus". The purpose of this study is to determine if three functional Magnetic Resonance brain imaging techniques: Magnetic Resonance Spectroscopy(MRS),Magnetic Resonance perfusion, and Diffusion Tensor Imaging(DTI) can detect brain alterations distinctive for neuropsychiatric systemic lupus erythematosus (...
What is the current status of trial NCT00730002?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2008-03. Estimated completion is 2014-12.
What conditions does trial NCT00730002 study?
This clinical trial studies the following conditions: Neuropsychiatric Systemic Lupus Erythematosus.
What interventions are being tested in trial NCT00730002?
The interventions under investigation include: Magnetic resonance imaging (PROCEDURE), Magnetic Resonance Angiography (MRA) (PROCEDURE), MRA (PROCEDURE), diffusion Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00730002?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00730002 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropsychiatric Systemic Lupus Erythematosus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.